Welcome to our dedicated page for Kp Tissue news (Ticker: KPTSF), a resource for investors and traders seeking the latest updates and insights on Kp Tissue stock.
KP Tissue Inc. reports recurring financial results for KP Tissue and Kruger Products, reflecting KP Tissue's equity-basis investment in Kruger Products. Company updates commonly center on quarterly results releases, conference calls and the performance context of Kruger Products' tissue manufacturing business.
News about the issuer also describes Kruger Products' consumer tissue brands, U.S. private label manufacturing, and Away-From-Home products for commercial and public entities.
KP Tissue (KPTSF) announced that its 2026 management proxy materials, including the management information circular, are available on its website and on SEDAR+.
The annual shareholder meeting is on June 15, 2026 at 11:00 a.m. ET in Toronto, with a proxy voting deadline of June 11, 2026.
KP Tissue (OTC:KPTSF) reported Q1 2026 results for its 12% holding, Kruger Products. Revenue was $544.6M, down 0.3% year-over-year, while Adjusted EBITDA rose 14.6% to $86.9M and net income reached $19.8M. Total liquidity was $461.9M.
KPT recorded $2.2M net income, including $2.4M from its share of Kruger Products’ earnings. The quarterly dividend was increased to $0.21 per share, payable July 15, 2026, and Q2 2026 Adjusted EBITDA is expected to be in the range of Q1 2026.
KP Tissue (KPTSF, TSX: KPT) will release first quarter 2026 financial results for both KP Tissue and Kruger Products on May 14, 2026 before market open. A conference call is scheduled for 8:30 a.m. Eastern Time with webcast and telephone access.
KP Tissue (OTC:KPTSF) said it will release first quarter 2026 financial results for KPT and Kruger Products on Thursday, May 14, 2026 before market open, and will host a conference call the same day at 8:30 a.m. ET.
Dial-in, webcast and rebroadcast details, plus presentation materials, will be available via the company website; replay access ends at midnight on May 21, 2026.